Literature DB >> 33136435

2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.

Paul A Heidenreich, Gregg C Fonarow, Khadijah Breathett, Corrine Y Jurgens, Barbara A Pisani, Bunny J Pozehl, John A Spertus, Kenneth G Taylor, Jennifer T Thibodeau, Clyde W Yancy, Boback Ziaeian.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; heart failure; performance measures; quality indicators; quality measures

Mesh：

Year:  2020        PMID： 33136435      PMCID： PMC8388013          DOI： 10.1161/HCQ.0000000000000099

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  123 in total

1.  Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE).

Authors:  Gregg C Fonarow; J Thomas Heywood; Paul A Heidenreich; Margarita Lopatin; Clyde W Yancy
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

2.  Long-term implications of a single home-based educational intervention in patients with heart failure.

Authors:  Ofelia Aguado; Cèsar Morcillo; Jordi Delàs; Mark Rennie; Siraj Bechich; Anna Schembari; Francesc Fernández; Franscesc Rosell
Journal:  Heart Lung       Date:  2010-07-03       Impact factor: 2.210

3.  Dose-dependent efficacy of β-blocker in patients with chronic heart failure and atrial fibrillation.

Authors:  Jeness Campodonico; Massimo Piepoli; Francesco Clemenza; Alice Bonomi; Stefania Paolillo; Elisabetta Salvioni; Ugo Corrà; Simone Binno; Fabrizio Veglia; Rocco Lagioia; Gianfranco Sinagra; Gaia Cattadori; Angela B Scardovi; Marco Metra; Michele Senni; Domenico Scrutinio; Rosa Raimondo; Michele Emdin; Damiano Magrì; Gianfranco Parati; Federica Re; Mariantonietta Cicoira; Chiara Minà; Giuseppe Limongelli; Michele Correale; Maria Frigerio; Maurizio Bussotti; Enrico Perna; Elisa Battaia; Marco Guazzi; Roberto Badagliacca; Andrea Di Lenarda; Aldo Maggioni; Claudio Passino; Susanna Sciomer; Giuseppe Pacileo; Massimo Mapelli; Carlo Vignati; Carlo Lombardi; Pasquale Perrone Filardi; Piergiuseppe Agostoni
Journal:  Int J Cardiol       Date:  2018-08-06       Impact factor: 4.164

4.  Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).

Authors:  Gregg C Fonarow; Nancy M Albert; Anne B Curtis; Wendy Gattis Stough; Mihai Gheorghiade; J Thomas Heywood; Mark L McBride; Patches Johnson Inge; Mandeep R Mehra; Christopher M O'Connor; Dwight Reynolds; Mary Norine Walsh; Clyde W Yancy
Journal:  Circulation       Date:  2010-07-26       Impact factor: 29.690

5.  Facility variation and predictors of serum potassium monitoring after initiation of a mineralocorticoid receptor antagonist in patients with heart failure.

Authors:  Vishal Chauhan; Sandesh Dev; Michael Pham; Shoutzu Lin; Paul Heidenreich
Journal:  Am Heart J       Date:  2015-06-15       Impact factor: 4.749

6.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

7.  Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.

Authors:  Marvin A Konstam; James D Neaton; Kenneth Dickstein; Helmut Drexler; Michel Komajda; Felipe A Martinez; Gunter A J Riegger; William Malbecq; Ronald D Smith; Soneil Guptha; Philip A Poole-Wilson
Journal:  Lancet       Date:  2009-11-16       Impact factor: 79.321

8.  Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET.

Authors:  Marco Metra; Christian Torp-Pedersen; John G F Cleland; Andrea Di Lenarda; Michel Komajda; Willem J Remme; Livio Dei Cas; Philip Spark; Karl Swedberg; Philip A Poole-Wilson
Journal:  Eur J Heart Fail       Date:  2007-06-19       Impact factor: 15.534

9.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Authors:  Marc A Pfeffer; John J V McMurray; Eric J Velazquez; Jean-Lucien Rouleau; Lars Køber; Aldo P Maggioni; Scott D Solomon; Karl Swedberg; Frans Van de Werf; Harvey White; Jeffrey D Leimberger; Marc Henis; Susan Edwards; Steven Zelenkofske; Mary Ann Sellers; Robert M Califf
Journal:  N Engl J Med       Date:  2003-11-10       Impact factor: 91.245

10.  Congestive heart failure patients' perceptions of quality of life: the integration of physical and psychosocial factors.

Authors:  H B Bosworth; K E Steinhauser; M Orr; J H Lindquist; S C Grambow; E Z Oddone
Journal:  Aging Ment Health       Date:  2004-01       Impact factor: 3.658
View more
  9 in total

Review 1.  Using Patient-Reported Outcomes toAssess Healthcare Quality: Toward Better Measurement of Patient-Centered Care in Cardiovascular Disease.

Authors:  Raul Angel Garcia; John A Spertus
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-04-05

2.  Is the affordable care act medicaid expansion associated with receipt of heart failure guideline-directed medical therapy by race and ethnicity?

Authors:  Khadijah K Breathett; Haolin Xu; Nancy K Sweitzer; Elizabeth Calhoun; Roland A Matsouaka; Clyde W Yancy; Gregg C Fonarow; Adam D DeVore; Deepak L Bhatt; Pamela N Peterson
Journal:  Am Heart J       Date:  2021-11-20       Impact factor: 4.749

3.  Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF Registry.

Authors:  Andy T Tran; Gregg C Fonarow; Suzanne V Arnold; Philip G Jones; Laine E Thomas; C Larry Hill; Adam D DeVore; Javed Butler; Nancy M Albert; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2021-10-07

Review 4.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

5.  Cardiologists' Perspectives on BiDil and the Use of Race in Drug Prescribing.

Authors:  Shawneequa L Callier; Perry W Payne; Deborah Akinniyi; Kaitlyn McPartland; Terry L Richardson; Mark A Rothstein; Charmaine D M Royal
Journal:  J Racial Ethn Health Disparities       Date:  2022-02-03

6.  Making heart failure count.

Authors:  Boback Ziaeian; Gregg C Fonarow
Journal:  Eur J Heart Fail       Date:  2021-03-18       Impact factor: 17.349

Review 7.  Applications of Tissue Decellularization Techniques in Ventricular Myocardial Biofabrication.

Authors:  Aravind Krishnan; Hanjay Wang; John Ward MacArthur
Journal:  Front Bioeng Biotechnol       Date:  2022-02-21

Review 8.  Patient-Reported Outcomes in Patients with Cardiomyopathy.

Authors:  Raul Angel Garcia; Mary C Benton; John A Spertus
Journal:  Curr Cardiol Rep       Date:  2021-06-14       Impact factor: 3.955

9.  Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study.

Authors:  Inge Schjødt; Søren P Johnsen; Anna Strömberg; Adam D DeVore; Jan B Valentin; Brian B Løgstrup
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.